# Study of Cadonilimab Combined With Bevacizumab and Chemotherapy for Advanced Nonsquamous Non-small Cell Lung Cancer Patients With Untreated Brain Metastases

> **NCT05812534** · PHASE2 · UNKNOWN · sponsor: **Second Affiliated Hospital of Nanchang University** · enrollment: 36 (estimated)

## Conditions studied

- Non Small Cell Lung Cancer
- Brain Metastases

## Interventions

- **DRUG:** Cadonilimab

## Key facts

- **NCT ID:** NCT05812534
- **Lead sponsor:** Second Affiliated Hospital of Nanchang University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-12
- **Primary completion:** 2024-06
- **Final completion:** 2025-06
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2023-11-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05812534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05812534, "Study of Cadonilimab Combined With Bevacizumab and Chemotherapy for Advanced Nonsquamous Non-small Cell Lung Cancer Patients With Untreated Brain Metastases". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05812534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*